To hear about similar clinical trials, please enter your email below
Trial Title:
Role of Left Stellate Ganglion Block in Offering Myocardial Protection in On-pump Mitral Valve Replacement? A Histopathological and Clinical Assessment
NCT ID:
NCT06476925
Condition:
Open Mitral Cardiac Surgery
Conditions: Official terms:
Ganglion Cysts
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Prevention
Masking:
Double (Participant, Outcomes Assessor)
Intervention:
Intervention type:
Procedure
Intervention name:
sonar guided stellate ganglion injection
Description:
using high frequency probe, sonar guided stellate ganglion block with 8 ml saline 0.9%
Arm group label:
Control group
Intervention type:
Procedure
Intervention name:
sonar guided stellate ganglion block
Description:
using high frequency probe, sonar guided stellate ganglion block with 8 ml bupivacaine
0.25%
Arm group label:
Stellate ganglion
Summary:
Can pre-operative left stellate ganglion block offer myocardial protection in on-pump
mitral valve replacement? A histopathological and clinical assessment.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Adult population of both sex, between 25-50 years, will undergo elective on pump
mitral valve replacement
Exclusion Criteria:
- -Combined valve replacement ( mitral and aortic or mitral and tricuspid valves
replacement).
- Emergency valve replacement ( stuck valve, infective endocarditis).
- Pre-operative cardiomyopathy (Ejection fraction less than 45%).
- Recent myocardial infarction ( within 6 months)
- Redo mitral valve replacement.
- Pre-operative pacing, or cardioverter, any form arrhythmia ( tachy or brady).
- Previous history of carotid endarterectomy or presence of carotid stent.
- On thrombolytic therapy.
- Severe chronic obstructive airway disease,
- Patient refusal
Gender:
All
Minimum age:
25 Years
Maximum age:
50 Years
Healthy volunteers:
No
Start date:
July 15, 2024
Completion date:
February 20, 2025
Lead sponsor:
Agency:
Minia University
Agency class:
Other
Source:
Minia University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06476925
